DrugPatentWatch Database Preview
Drugs in Development Information for GS-0976
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for GS-0976?
GS-0976 is an investigational drug.
There have been 6 clinical trials for GS-0976.
The most recent clinical trial was a Phase 1 trial, which was initiated on August 1st 2016.
The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Liver Diseases. The leading clinical trial sponsors are Gilead Sciences, Novo Nordisk A/S, and Nimbus Apollo.
There are three US patents protecting this investigational drug and sixty-one international patents.
Summary for GS-0976
| US Patents | 3 |
| International Patents | 61 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2016-08-01) |
| Vendors | 15 |
Recent Clinical Trials for GS-0976
| Title | Sponsor | Phase |
|---|---|---|
| Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Adults With Nonalcoholic Steatohepatitis (NASH) | Novo Nordisk A/S | Phase 2 |
| Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Adults With Nonalcoholic Steatohepatitis (NASH) | Gilead Sciences | Phase 2 |
| Safety and Efficacy of Selonsertib, GS-0976, GS-9674, and Combinations in Participants With Bridging Fibrosis or Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) | Gilead Sciences | Phase 2 |
Clinical Trial Summary for GS-0976
Top disease conditions for GS-0976
Top clinical trial sponsors for GS-0976
US Patents for GS-0976
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| GS-0976 | Start Trial | Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof | Gilead Apollo, LLC (Foster City, CA) | Start Trial |
| GS-0976 | Start Trial | ACC inhibitors and uses thereof | Nimbus Apollo, Inc. (Cambridge, MA) | Start Trial |
| GS-0976 | Start Trial | ACC inhibitors and uses thereof | Gilead Apollo, LLC (Foster City, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for GS-0976
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| GS-0976 | Argentina | 107790 | 2036-03-02 | Start Trial |
| GS-0976 | Australia | 2017226267 | 2036-03-02 | Start Trial |
| GS-0976 | Brazil | 112018067408 | 2036-03-02 | Start Trial |
| GS-0976 | Canada | 3015526 | 2036-03-02 | Start Trial |
| GS-0976 | China | 108699078 | 2036-03-02 | Start Trial |
| GS-0976 | Eurasian Patent Organization | 201891692 | 2036-03-02 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
